Fluticasone/Umeclidin/Vilanter
Brand name: Trelegy Ellipta
Rank #9 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$1.81B
Total Cost
2,046,216
Total Claims
$1.81B
Total Cost
36,178
Prescribers
$885
Cost per Claim
368,651
Beneficiaries
2,714,181
30-Day Fills
$50K
Avg Cost/Provider
57
Avg Claims/Provider
Share of Medicare Part D Spending
0.66%
of total Medicare Part D spending
$1.81B of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $1.81B total
🔎 Data Overview
Fluticasone/Umeclidin/Vilanter is the #9 most expensive drug in Medicare Part D, costing taxpayers $1.81B in 2023. The top 10 drugs alone account for roughly 20% of all Part D spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Fluticasone/Umeclidin/Vilanter
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Kaiser Toosy | Pulmonary Disease | New Haven, CT | 2,412 | $2.3M |
| 2 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 2,391 | $1.6M |
| 3 | Rajesh Agrawal | Pulmonary Disease | Pinellas Park, FL | 1,968 | $1.6M |
| 4 | Ahmed Bhatti | Pulmonary Disease | Granbury, TX | 1,931 | $1.5M |
| 5 | Hoang Le | Pulmonary Disease | Fountain Valley, CA | 1,535 | $1.5M |
| 6 | Gaurav Sangwan | Pulmonary Disease | Springfield, IL | 1,616 | $1.4M |
| 7 | Jason Karp | Pulmonary Disease | Lake Success, NY | 1,145 | $1.3M |
| 8 | Ernesto Mejia | Pulmonary Disease | Morristown, TN | 1,553 | $1.3M |
| 9 | Richard Miller | Pulmonary Disease | Newark, NJ | 1,668 | $1.3M |
| 10 | Elizabeth Kluka | Critical Care (Intensivists) | Kalamazoo, MI | 1,679 | $1.3M |
| 11 | Ahmad Ibrahimbacha | Pulmonary Disease | Cleveland, TN | 1,519 | $1.2M |
| 12 | Walid Eltaraboulsi | Pulmonary Disease | Charlotte, NC | 1,258 | $1.2M |
| 13 | Gary Schafer | Pulmonary Disease | Forest City, NC | 1,381 | $1.2M |
| 14 | Magendra Thakur | Sleep Medicine | Potsdam, NY | 1,088 | $1.2M |
| 15 | Vivek Sambhara | Pulmonary Disease | Gainesville, GA | 1,139 | $1.2M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 6 | Adalimumab (Humira(Cf) Pen) | $2.17B | 240,925 |
| 7 | Lenalidomide (Revlimid) | $2.15B | 130,834 |
| 8 | Insulin Glargine,hum.Rec.Anlog (Lantus Solostar) | $1.94B | 3,118,259 |
| 9 | Fluticasone/Umeclidin/Vilanter (Trelegy Ellipta) | $1.81B | 2,046,216 |
| 10 | Dapagliflozin Propanediol (Farxiga) | $1.65B | 1,666,200 |
| 11 | Sitagliptin Phosphate (Januvia) | $1.54B | 1,567,668 |
| 12 | Sacubitril/Valsartan (Entresto) | $1.30B | 1,220,812 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology